🇺🇸 FDA
Patent

US 6043212

Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor

expired A61KA61K38/00A61K48/00

Quick answer

US patent 6043212 (Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor) held by COR Therapeutics, Inc. expires Mon Mar 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
COR Therapeutics, Inc.
Grant date
Tue Mar 28 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00, A61K48/00